{"allTrials": {"@totalCount": "5", "@xmlns": "http://www.67bricks.com/isrctn", "fullTrial": [{"trial": {"@lastUpdated": "2012-09-27T00:00:00.000Z", "@version": "19", "isrctn": {"@dateAssigned": "2007-09-28T00:00:00.000Z", "#text": "36705800"}, "trialDescription": {"@thirdPartyFilesAcknowledgement": "false", "acknowledgment": "true", "title": "An Evaluation of Speech and Language Therapy (SLT) Treatment Strategies for CVA patients with Dysphagia", "scientificTitle": null, "acronym": null, "studyHypothesis": "Do dysphagic stroke patients managed with thickened fluids have outcomes which are equally as good as patients managed with other SLT treatment strategies?", "plainEnglishSummary": "Not provided at time of registration", "primaryOutcome": "Added May 2008:\n1. Number and frequency of chest infections\n2. Episodes of dehydration", "secondaryOutcome": "Added May 2008:\nPatient and carer compliance with interventions", "trialWebsite": null, "ethicsApprovalRequired": "Old ethics approval format", "ethicsCommittees": null, "ethicsApproval": "Added May 2008:\nNorth Sheffield Local Research Ethics Committee. Date approved 19/4/06. REC No 06/Q2308/33."}, "externalRefs": {"doi": "10.1186/ISRCTN36705800", "eudraCTNumber": null, "irasNumber": null, "clinicalTrialsGovNumber": null, "protocolSerialNumber": "N0059182017"}, "trialDesign": {"studyDesign": "Randomised controlled trial", "primaryStudyDesign": "Interventional", "secondaryStudyDesign": "Randomised controlled trial", "trialSettings": {"trialSetting": "Hospital"}, "trialTypes": {"trialType": "Treatment"}, "overallStatusOverride": null, "reasonAbandoned": null, "overallStartDate": "2005-12-01T00:00:00.000Z", "overallEndDate": "2009-03-01T00:00:00.000Z"}, "participants": {"recruitmentCountries": {"country": ["England", "United Kingdom"]}, "trialCentres": {"trialCentre": {"@id": "30541635-3191-48fb-9df7-23fdf340786b", "name": "STH NHS Foundation Trust", "address": null, "city": "Sheffield", "state": null, "country": "United Kingdom", "zip": "S10 2JF"}}, "participantTypes": {"participantType": "Patient"}, "inclusion": "Patients admitted to Sheffield Teaching Hospitals with a diagnosis of stroke who are referred to Speech & Language Therapy Dept with a diagnosis of dysphagia.", "ageRange": "Adult", "gender": "Not Specified", "targetEnrolment": "50", "totalFinalEnrolment": null, "totalTarget": "50", "exclusion": "Added May 2008:\nAdults presenting with moderate or severe dysphasia", "patientInfoSheet": "Not available in web format, please use the contact details below to request a patient information sheet", "recruitmentStart": "2005-12-01T00:00:00.000Z", "recruitmentEnd": "2009-03-01T00:00:00.000Z", "recruitmentStatusOverride": null}, "conditions": {"condition": {"description": "Stroke patients presenting with dysphagia", "diseaseClass1": "Signs and Symptoms", "diseaseClass2": "Dysphagia"}}, "interventions": {"intervention": {"description": "Thickened fluids vs swallowing / postural modifications", "interventionType": "Other", "pharmaceuticalStudyTypes": null, "phase": "Not Specified", "drugNames": null}}, "results": {"publicationPlan": "Not provided at time of registration", "ipdSharingStatement": null, "dataPolicies": {"dataPolicy": "Not provided at time of registration"}, "publicationDetails": null, "publicationStage": null, "biomedRelated": "false", "basicReport": null, "plainEnglishReport": null}, "outputs": null, "parties": {"funderId": ["Funder16996-0", "Funder16996-1"], "contactId": "Contact54957_16996", "sponsorId": "Sponsor53522"}, "miscellaneous": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "ipdSharingPlan": "No"}, "attachedFiles": null}, "contact": {"@id": "Contact54957_16996", "title": "Prof", "forename": "Timothy", "surname": "Hendra", "orcid": null, "contactTypes": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "contactType": "Scientific"}, "contactDetails": {"address": "STH NHS Foundation Trust\nGeriatric Medicine\nQ Floor\nRoyal Hallamshire Hospital", "city": "Sheffield", "country": "United Kingdom", "zip": "S10 2JF", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+44 0114 226 6419"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}}, "privacy": "Public"}, "sponsor": {"@id": "Sponsor53522", "organisation": "Record Provided by the NHSTCT Register - 2007 Update - Department of Health", "website": "http://www.dh.gov.uk/Home/fs/en", "sponsorType": "Government", "contactDetails": {"address": "The Department of Health, Richmond House, 79 Whitehall", "city": "London", "country": "United Kingdom", "zip": "SW1A 2NL", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+44 (0)20 7307 2622"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "dhmail@doh.gsi.org.uk"}}, "privacy": "Public"}, "funder": [{"@id": "Funder16996-0", "name": "Sheffield Teaching Hospitals NHS Foundation Trust (UK)", "fundRef": null}, {"@id": "Funder16996-1", "name": "NHS R&D Support Funding", "fundRef": null}]}, {"trial": {"@lastUpdated": "2012-09-27T00:00:00.000Z", "@version": "21", "isrctn": {"@dateAssigned": "2007-09-28T00:00:00.000Z", "#text": "83029560"}, "trialDescription": {"@thirdPartyFilesAcknowledgement": "false", "acknowledgment": "true", "title": "Pursed Lip Breathing (PLB) and its role in the management of breathlessness in stable chronic obstructive pulmonary disease (COPD)", "scientificTitle": null, "acronym": null, "studyHypothesis": "Does pursed lip breathing improve quality of life in patients with stable Chronic Obstructive Pulmonary Disease, in whom activities of daily living are limited by breathlessness?", "plainEnglishSummary": "Not provided at time of registration", "primaryOutcome": "Added July 2008:\n1. Chronic Respiratory Disease Questionnaire\n2. Endurance Shuttle Walk Test", "secondaryOutcome": "Added July 2008:\n1. Borg Dyspnoea Scale\n2. Respiratory rate and inspiratory capacity pre and post exercise\n3. Hospital Anxiety and Depression scale", "trialWebsite": null, "ethicsApprovalRequired": "Old ethics approval format", "ethicsCommittees": null, "ethicsApproval": "Added July 2008: \nMoorfields and Whittington Local Research Ethics Committee, 05/Q0504/93, favourable opinion granted 08/02/06."}, "externalRefs": {"doi": "10.1186/ISRCTN83029560", "eudraCTNumber": null, "irasNumber": null, "clinicalTrialsGovNumber": null, "protocolSerialNumber": "N0277185567"}, "trialDesign": {"studyDesign": "Randomised, controlled, single blind study", "primaryStudyDesign": "Interventional", "secondaryStudyDesign": "Randomised controlled trial", "trialSettings": {"trialSetting": "Hospital"}, "trialTypes": {"trialType": "Quality of life"}, "overallStatusOverride": null, "reasonAbandoned": null, "overallStartDate": "2006-03-01T00:00:00.000Z", "overallEndDate": "2009-03-01T00:00:00.000Z"}, "participants": {"recruitmentCountries": {"country": ["England", "United Kingdom"]}, "trialCentres": {"trialCentre": {"@id": "15c528e0-8d2e-4eeb-88ed-207d3c91b0fa", "name": "Whittington Hospital NHS Trust", "address": null, "city": "London", "state": null, "country": "United Kingdom", "zip": "N19 5NF"}}, "participantTypes": {"participantType": "Patient"}, "inclusion": "Prior to July 2008:\n1. Non smoking patients that have been diagnosed with COPD who are in a stable condition.\n2. 86 participants, broken down as approximately 4/5th will be recruited from The Whittington NHS and 1/5th from Islington PCT.\n\nModified July 2008:\n1. Diagnosis of COPD (FEV1 < 80% and FEV1/FVC < 70% predicted)\n2. Medical intervention optimised according to NICE guidelines\n3. MRC 3 or more; as a minimum walks slower than contemporaries on level ground or has to stop for breathing when walking at own pace \n4. 4/52 since last exacerbation and 6/52 since last admission \n5.Informed consent obtained and signed after provision of information sheet\n6. Able to comply with study procedure", "ageRange": "Not Specified", "gender": "Not Specified", "targetEnrolment": "46", "totalFinalEnrolment": null, "totalTarget": "Prior to July 2008: 86. As of July 2008: 46", "exclusion": "Added July 2008:\n1. Subject requires an interpreter for consent form\n2. Mini-mental test score < 24 (performed in English) \n3. Subject has no fixed abode or does not consent to home visits \n4. Hospital Lone Practioner Policy precludes home visits to this subject \n5. Previously taught PLB \n6. On long term oxygen therapy (LTOT) \n7. Medical history preventing ability to walk (other than COPD) \n8. Ex-smoker of < 3 months \n9. Unstable Angina \n10. Uncontrolled hypertension \n11. Uncontrolled congestive cardiac failure \n12. Uncontrolled cardiac arrhythmias \n13. Myocardial infarct within 6 weeks", "patientInfoSheet": "Not available in web format, please use the contact details below to request a patient information sheet", "recruitmentStart": "2006-03-01T00:00:00.000Z", "recruitmentEnd": "2009-03-01T00:00:00.000Z", "recruitmentStatusOverride": null}, "conditions": {"condition": {"description": "Respiratory: Chronic obstructive pulmonary disease (COPD)", "diseaseClass1": "Respiratory", "diseaseClass2": "Chronic obstructive pulmonary disease (COPD)"}}, "interventions": {"intervention": {"description": "Pursed Lip Breathing (PLB) vs control", "interventionType": "Other", "pharmaceuticalStudyTypes": null, "phase": "Not Specified", "drugNames": null}}, "results": {"publicationPlan": "Not provided at time of registration", "ipdSharingStatement": null, "dataPolicies": {"dataPolicy": "Not provided at time of registration"}, "publicationDetails": "2011 Results article in http://thorax.bmj.com/content/66/Suppl_4/A175.2.short results", "publicationStage": "Results", "biomedRelated": "false", "basicReport": null, "plainEnglishReport": null}, "outputs": {"output": {"@id": "d7f4e2a7-b2c4-4dfe-ab22-76f72f9dd49d", "@outputType": "resultsarticle", "@artefactType": "ExternalLink", "@dateCreated": "2011-12-01T00:00:00.000Z", "@dateUploaded": "", "@peerReviewed": "true", "@patientFacing": "false", "@createdBy": "Data migration", "externalLink": {"@url": "http://thorax.bmj.com/content/66/Suppl_4/A175.2.short"}, "description": "results", "productionNotes": null}}, "parties": {"funderId": "Funder17116-0", "contactId": "Contact55077_17116", "sponsorId": "Sponsor53642"}, "miscellaneous": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "ipdSharingPlan": "No"}, "attachedFiles": null}, "contact": {"@id": "Contact55077_17116", "title": "Mrs", "forename": "Suzanne E", "surname": "Roberts", "orcid": null, "contactTypes": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "contactType": "Scientific"}, "contactDetails": {"address": "Whittington Hospital NHS Trust \nDept of Physiotherapy \nThe Whittingotn Hospital \nMagdala Avenue", "city": "London", "country": "United Kingdom", "zip": "N19 5NF", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+44 020 7288 5660"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "suzanne.Roberts@whittington.nhs.uk"}}, "privacy": "Public"}, "sponsor": {"@id": "Sponsor53642", "organisation": "Record Provided by the NHSTCT Register - 2007 Update - Department of Health", "website": "http://www.dh.gov.uk/Home/fs/en", "sponsorType": "Government", "contactDetails": {"address": "The Department of Health, Richmond House, 79 Whitehall", "city": "London", "country": "United Kingdom", "zip": "SW1A 2NL", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+44 (0)20 7307 2622"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "dhmail@doh.gsi.org.uk"}}, "privacy": "Public"}, "funder": {"@id": "Funder17116-0", "name": "Whittington Hospital NHS Trust (UK)", "fundRef": null}}, {"trial": {"@lastUpdated": "2012-09-27T00:00:00.000Z", "@version": "22", "isrctn": {"@dateAssigned": "2007-09-28T00:00:00.000Z", "#text": "07665287"}, "trialDescription": {"@thirdPartyFilesAcknowledgement": "false", "acknowledgment": "true", "title": "Guided self-help for eating disorders: A randomised controlled trial", "scientificTitle": null, "acronym": null, "studyHypothesis": "This study aims to evaluate the effectiveness of this GSH (Guided Self Help) pack in both primary and secondary care as delivered by trained, supervised mental health professionals.\n\nUntil 15/05/08:\n-  the title was: Guided self-help for eating disorders in primary care\n-  the end date was 31/12/07", "plainEnglishSummary": "Not provided at time of registration", "primaryOutcome": "It would evaluate the outcome of using the pack as compared to a group of people on the waiting list (in terms of mental health, and eating disordered behaviour and psychopathology), the effect of the therapeutic alliance on the GSH and the adherence to and usefulness of the pack as rated by users.", "secondaryOutcome": "Not provided at time of registration", "trialWebsite": null, "ethicsApprovalRequired": "Old ethics approval format", "ethicsCommittees": null, "ethicsApproval": "Added 15/05/08:  \nLeeds (East) Research Ethics Committee 06/Q1206/51"}, "externalRefs": {"doi": "10.1186/ISRCTN07665287", "eudraCTNumber": null, "irasNumber": null, "clinicalTrialsGovNumber": null, "protocolSerialNumber": "N0626191789"}, "trialDesign": {"studyDesign": "Randomised controlled trial", "primaryStudyDesign": "Interventional", "secondaryStudyDesign": "Randomised controlled trial", "trialSettings": {"trialSetting": "Not specified"}, "trialTypes": {"trialType": "Prevention"}, "overallStatusOverride": null, "reasonAbandoned": null, "overallStartDate": "2006-07-01T00:00:00.000Z", "overallEndDate": "2009-08-31T00:00:00.000Z"}, "participants": {"recruitmentCountries": {"country": ["England", "United Kingdom"]}, "trialCentres": {"trialCentre": {"@id": "b012b71e-c945-4288-b94f-025066c773cb", "name": "University of Leeds", "address": null, "city": "Leeds", "state": null, "country": "United Kingdom", "zip": "LS2 9LJ"}}, "participantTypes": {"participantType": "Patient"}, "inclusion": "Participants for the research will be recruited from people accessing primary or secondary mental health care.", "ageRange": "Adult", "gender": "Not Specified", "targetEnrolment": "70", "totalFinalEnrolment": null, "totalTarget": "Added 15/05/08: 70", "exclusion": "Added 15/05/08:\n1. BMI<16 or rapid weight loss\n2. <16 years of age\n3. If primary difficulty is not an eating disorder\n4. High risk of self-harm or suicide\n5. Abusing drugs or alcohol\n6. Severe depression\n7. Major co-morbid physical disorder", "patientInfoSheet": "Not available in web format, please use the contact details below to request a patient information sheet", "recruitmentStart": "2006-07-01T00:00:00.000Z", "recruitmentEnd": "2009-08-31T00:00:00.000Z", "recruitmentStatusOverride": null}, "conditions": {"condition": {"description": "Mental and Behavioural Disorders: Eating disorder", "diseaseClass1": "Mental and Behavioural Disorders", "diseaseClass2": "Eating disorder"}}, "interventions": {"intervention": {"description": "A mail shot of GPs able to refer the trained guides will inform GPs of the research project and help them to identify appropriate patients/participants.  Once referred to the guide the participant will undergo that guide's service routine screening or assessment process. If the participant meets the inclusion criteria, the project is explained to them verbally and in writing. The participant is also asked to make an appointment with their GP to obtain any relevant blood tests and get their BMI.  If a participant is not suitable to participate or does not wish to, they receive the treatment as usual from the service. After consent is given the guide contacts the researcher sending her the consent form.  Participants details are anonymised and a code is used.  \nThe research randomises the participant to GSH or waiting list control. People randomised to the waiting list control group will remain on the service's waiting list for the amount of time they would usually have done if they were not taking part in the research. The researcher will also contact the participants GP to inform them of the participants involvement in the project.", "interventionType": "Other", "pharmaceuticalStudyTypes": null, "phase": "Not Specified", "drugNames": null}}, "results": {"publicationPlan": "Not provided at time of registration", "ipdSharingStatement": null, "dataPolicies": {"dataPolicy": "Not provided at time of registration"}, "publicationDetails": "2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21092933 results", "publicationStage": "Results", "biomedRelated": "false", "basicReport": null, "plainEnglishReport": null}, "outputs": {"output": {"@id": "f92c90a7-3405-4f8e-90d2-b1c7181c7042", "@outputType": "resultsarticle", "@artefactType": "ExternalLink", "@dateCreated": "2011-01-01T00:00:00.000Z", "@dateUploaded": "", "@peerReviewed": "true", "@patientFacing": "false", "@createdBy": "Data migration", "externalLink": {"@url": "http://www.ncbi.nlm.nih.gov/pubmed/21092933"}, "description": "results", "productionNotes": null}}, "parties": {"funderId": "Funder17144-0", "contactId": "Contact55105_17144", "sponsorId": "Sponsor53670"}, "miscellaneous": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "ipdSharingPlan": "No"}, "attachedFiles": null}, "contact": {"@id": "Contact55105_17144", "title": "Ms", "forename": "Gemma", "surname": "Traviss", "orcid": null, "contactTypes": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "contactType": "Scientific"}, "contactDetails": {"address": "University of Leeds\nLeeds Institute of Health Sciences\nCharles Thackrah Building\n101 Clarendon Road", "city": "Leeds", "country": "United Kingdom", "zip": "LS2 9LJ", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+44"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "umgt@leeds.ac.uk"}}, "privacy": "Public"}, "sponsor": {"@id": "Sponsor53670", "organisation": "Record Provided by the NHSTCT Register - 2007 Update - Department of Health", "website": "http://www.dh.gov.uk/Home/fs/en", "sponsorType": "Government", "contactDetails": {"address": "The Department of Health, Richmond House, 79 Whitehall", "city": "London", "country": "United Kingdom", "zip": "SW1A 2NL", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+44 (0)20 7307 2622"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "dhmail@doh.gsi.org.uk"}}, "privacy": "Public"}, "funder": {"@id": "Funder17144-0", "name": "Leeds Partnership Foundation NHS Trust (UK)", "fundRef": null}}, {"trial": {"@lastUpdated": "2012-09-27T00:00:00.000Z", "@version": "24", "isrctn": {"@dateAssigned": "2006-06-19T00:00:00.000Z", "#text": "53707238"}, "trialDescription": {"@thirdPartyFilesAcknowledgement": "false", "acknowledgment": "true", "title": "A Phase III randomised, double-blind, multicentre study to evaluate the safety and efficacy of 1592U89 (abacavir) in human immunodeficiency virus 1-infected patients with aquired immune deficiency syndrome dementia complex", "scientificTitle": null, "acronym": null, "studyHypothesis": "The addition of abacavir to an antiretroviral regimen in patients with aquired immune deficiency syndrome (AIDS) dementia will lead to improved neuropsychological performance", "plainEnglishSummary": "Not provided at time of registration", "primaryOutcome": "Improvement in neuropsychological performance.", "secondaryOutcome": "Reduction in cerebrospinal fluid HIV viral load.", "trialWebsite": "http://ctr.gsk.co.uk/summary/abacavir/III_CNAB3001.pdf", "ethicsApprovalRequired": "Old ethics approval format", "ethicsCommittees": null, "ethicsApproval": "This study was reviewed and approved by Riverside Ethics Committee, Chelsea and Westminster Hospital on 05/12/1996, reference number: 1163"}, "externalRefs": {"doi": "10.1186/ISRCTN53707238", "eudraCTNumber": null, "irasNumber": null, "clinicalTrialsGovNumber": "NCT00002163", "protocolSerialNumber": "CNAB 3001"}, "trialDesign": {"studyDesign": "Randomised, double-blind, placebo-controlled study", "primaryStudyDesign": "Interventional", "secondaryStudyDesign": "Randomised controlled trial", "trialSettings": {"trialSetting": "Not specified"}, "trialTypes": {"trialType": "Treatment"}, "overallStatusOverride": null, "reasonAbandoned": null, "overallStartDate": "1996-09-03T00:00:00.000Z", "overallEndDate": "1998-01-08T00:00:00.000Z"}, "participants": {"recruitmentCountries": {"country": ["Australia", "Canada", "United Kingdom", "United States of America"]}, "trialCentres": {"trialCentre": {"@id": "86583ed7-5695-42d8-8843-93a565279f09", "name": "Department of Neurology", "address": null, "city": "Sydney", "state": null, "country": "Australia", "zip": "2010"}}, "participantTypes": {"participantType": "Patient"}, "inclusion": "Confirmed human immunodeficiency virus-1 (HIV-1) seropositive male or female subjects, aged 18 to 65 years, diagnosed with stage 1 or 2 (mild to moderate) AIDS dementia complex and stable on current antiretroviral therapy for a minimum of eight weeks prior to study entry were enrolled. Subjects were impaired by at least 1.5 standard deviations (SDs) below normal in at least two neuropsychological domains from the neuropsychological test battery", "ageRange": "Adult", "lowerAgeLimit": {"@unit": "Years", "@value": "18.0"}, "gender": "Both", "targetEnrolment": "90", "totalFinalEnrolment": null, "totalTarget": "90", "exclusion": "Subjects with evidence of confounding neurological disease or presenting with other central nervous system (CNS) opportunistic infections or neoplasms were excluded", "patientInfoSheet": null, "recruitmentStart": "1996-09-03T00:00:00.000Z", "recruitmentEnd": "1998-01-08T00:00:00.000Z", "recruitmentStatusOverride": null}, "conditions": {"condition": {"description": "HIV-1 infection with AIDS dementia", "diseaseClass1": "Infections and Infestations", "diseaseClass2": "HIV, AIDS"}}, "interventions": {"intervention": {"description": "Subjects were pre-stratified into group A or B depending on whether their respective existing therapy contained zidovudine (ZDV) or not.\nSubjects receiving stavudine (d4T) were stratified into group B. Study participants were randomized within each stratum to receive either 600 mg of abacavir (ABC) or matched placebo every twelve hours in addition to their current antiretroviral therapy for the first 12 weeks of the study.\nAt the end of the randomized phase or at the time of AIDS dementia complex (ADC) progression, or severe antiretroviral drug toxicity not related to ABC, there was the option of continuing the study further for 40 weeks receiving open label ABC.", "interventionType": "Drug", "pharmaceuticalStudyTypes": null, "phase": "Phase III", "drugNames": "1592U89 (Abacavir)"}}, "results": {"publicationPlan": "Not provided at time of registration", "ipdSharingStatement": null, "dataPolicies": {"dataPolicy": "Not provided at time of registration"}, "publicationDetails": "2001 Results article in http://www.ncbi.nlm.nih.gov/pubmed/11371689 results", "publicationStage": "Results", "biomedRelated": "false", "basicReport": null, "plainEnglishReport": null}, "outputs": {"output": {"@id": "740b77dc-811e-4e11-8a5d-923c1f4be6b5", "@outputType": "resultsarticle", "@artefactType": "ExternalLink", "@dateCreated": "2001-04-13T00:00:00.000Z", "@dateUploaded": "", "@peerReviewed": "true", "@patientFacing": "false", "@createdBy": "Data migration", "externalLink": {"@url": "http://www.ncbi.nlm.nih.gov/pubmed/11371689"}, "description": "results", "productionNotes": null}}, "parties": {"funderId": ["Funder14921-0", "Funder14921-1"], "contactId": "Contact52713_14921", "sponsorId": "Sponsor51251"}, "miscellaneous": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "ipdSharingPlan": "No"}, "attachedFiles": null}, "contact": {"@id": "Contact52713_14921", "title": "Prof", "forename": "Bruce", "surname": "Brew", "orcid": null, "contactTypes": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "contactType": "Scientific"}, "contactDetails": {"address": "Department of Neurology\nLevel 4 Xavier\nSt Vincent's Hospital", "city": "Sydney", "country": "Australia", "zip": "2010", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+61 (0)2 8382 4100"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "b.brew@unsw.edu.au"}}, "privacy": "Public"}, "sponsor": {"@id": "Sponsor51251", "organisation": "GlaxoSmithKline (UK)", "website": "http://www.gsk.com", "sponsorType": "Industry", "contactDetails": {"address": "Stockley Park West\nUxbridge", "city": "Middlesex", "country": "United Kingdom", "zip": "UB11 1BT", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+44 (0)208 9909000"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "carolyn.2.goodwin@gsk.com"}}, "privacy": "Public", "gridId": "grid.418236.a", "rorId": "https://ror.org/01xsqw823"}, "funder": [{"@id": "Funder14921-0", "name": "GlaxoSmithKline", "fundRef": "http://dx.doi.org/10.13039/100004330"}, {"@id": "Funder14921-1", "name": "NIH grants: NS44807 (McArthur JC) and NS094659 (McArthur JC)", "fundRef": null}]}, {"trial": {"@lastUpdated": "2012-09-27T00:00:00.000Z", "@version": "19", "isrctn": {"@dateAssigned": "2003-09-12T00:00:00.000Z", "#text": "27431428"}, "trialDescription": {"@thirdPartyFilesAcknowledgement": "false", "acknowledgment": "true", "title": "A study to investigate the effect of heating and humidifying laparoscopic insufflation gas on post laparoscopic pain", "scientificTitle": null, "acronym": null, "studyHypothesis": "The aim of the study is to find out if women will have less pain after their laparoscopy if the gas used during the operation is not as dry and contains more water.", "plainEnglishSummary": "Not provided at time of registration", "primaryOutcome": "Post-operative shoulder tip pain.", "secondaryOutcome": "Analgesia used and the length of time taken to return to normal activities.", "trialWebsite": null, "ethicsApprovalRequired": "Old ethics approval format", "ethicsCommittees": null, "ethicsApproval": "Not provided at time of registration"}, "externalRefs": {"doi": "10.1186/ISRCTN27431428", "eudraCTNumber": null, "irasNumber": null, "clinicalTrialsGovNumber": null, "protocolSerialNumber": "N0084113224"}, "trialDesign": {"studyDesign": "Randomised controlled trial", "primaryStudyDesign": "Interventional", "secondaryStudyDesign": "Randomised controlled trial", "trialSettings": {"trialSetting": "Hospital"}, "trialTypes": {"trialType": "Treatment"}, "overallStatusOverride": null, "reasonAbandoned": null, "overallStartDate": "2002-01-31T00:00:00.000Z", "overallEndDate": "2005-12-01T00:00:00.000Z"}, "participants": {"recruitmentCountries": {"country": ["England", "United Kingdom"]}, "trialCentres": {"trialCentre": {"@id": "b512d330-da5d-4083-9ea0-ac59d08b767e", "name": "Hull and East Yorks Hospital Trust", "address": null, "city": "Hull", "state": null, "country": "United Kingdom", "zip": "HU8 9HE"}}, "participantTypes": {"participantType": "Patient"}, "inclusion": "Women undergoing laparoscopic surgery for sterilisation or tubal patency testing will be given the opportunity to participate in the study. Subjects will be randomly allocated to one of the four groups.", "ageRange": "Not Specified", "gender": "Female", "targetEnrolment": "0", "totalFinalEnrolment": null, "totalTarget": "Not provided at time of registration", "exclusion": "Not provided at time of registration", "patientInfoSheet": null, "recruitmentStart": "2002-01-31T00:00:00.000Z", "recruitmentEnd": "2005-12-01T00:00:00.000Z", "recruitmentStatusOverride": null}, "conditions": {"condition": {"description": "Signs and Symptoms: Pain", "diseaseClass1": "Signs and Symptoms", "diseaseClass2": "Pain"}}, "interventions": {"intervention": {"description": "1. CO2 unheated and unhumified\n2. CO2 heated but unhumified\n3. CO2 unheated but humified\n4. CO2 heated and humified\n\nThe surgeon, patient and main researcher will be blinded and only the anaesthetist will be aware of the gas used. In all cases the gas will be collected when the peritoneum is decompressed after surgery and the volume and water content measured as an estimate of water loss.\n\nPost operative pain will be assessed using a visual response scale at 1, 2, 3 h and the evening of the operation and also the first, second and seventh day post laparoscopy. Responses will be requested for pain at the site of the wounds, pain in the pelvis and shoulder tip pain.", "interventionType": "Other", "pharmaceuticalStudyTypes": null, "phase": "Not Specified", "drugNames": null}}, "results": {"publicationPlan": "Not provided at time of registration", "ipdSharingStatement": null, "dataPolicies": {"dataPolicy": "Not provided at time of registration"}, "publicationDetails": null, "publicationStage": null, "biomedRelated": "false", "basicReport": null, "plainEnglishReport": null}, "outputs": null, "parties": {"funderId": "Funder5350-0", "contactId": "Contact6636_5350", "sponsorId": "Sponsor5287"}, "miscellaneous": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "ipdSharingPlan": "No"}, "attachedFiles": null}, "contact": {"@id": "Contact6636_5350", "title": "Ms", "forename": "Teresa", "surname": "Doto", "orcid": null, "contactTypes": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "contactType": "Scientific"}, "contactDetails": {"address": "Hull and East Yorks Hospital Trust\nThe Princess Royal Hospital\nSalthouse Road", "city": "Hull", "country": "United Kingdom", "zip": "HU8 9HE", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}}, "privacy": "Public"}, "sponsor": {"@id": "Sponsor5287", "organisation": "Department of Health (UK)", "website": "http://www.doh.gov.uk", "sponsorType": "Government", "contactDetails": {"address": "Richmond House\n79 Whitehall", "city": "London", "state": null, "country": "United Kingdom", "zip": "SW1A 2NL", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}}, "privacy": "Protected"}, "funder": {"@id": "Funder5350-0", "name": "The North and South Bank Research and Development Consortium (UK)", "fundRef": null}}]}}